Gastrointestinal Stromal Tumor (GIST) Market to Observe Stupendous Growth During the Forecast Period (2019-32) | Key Players – Advenchen, Deciphera, Pfizer, Bayer, Novartis, Arog Pharma, Taiho Oncology

June 23 20:56 2022
Gastrointestinal Stromal Tumor (GIST) Market to Observe Stupendous Growth During the Forecast Period (2019-32) | Key Players - Advenchen, Deciphera, Pfizer, Bayer, Novartis, Arog Pharma, Taiho Oncology
Delveinsight Business Research LLP
DelveInsight’s “Gastrointestinal Stromal Tumor (GIST) Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Gastrointestinal Stromal Tumor Market size, share, and trends in the seven major market (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan).

The Gastrointestinal Stromal Tumor market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2019 to 2032. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Gastrointestinal Stromal Tumor Market

Gastrointestinal Stromal Tumor: An Overview

A Gastrointestinal Stromal Tumor (GIST) is rare cancer affecting the digestive tract or nearby structures within the abdomen. It is a sarcoma that arises either from cells called Interstitial Cells of Cajal (ICCs) or from less differentiated stem cells or precursor cells that can develop into ICCs.

Because GIST cancers arise from the GI tract wall, they are usually attached to the outside of the involved organ, growing outward; this is sometimes referred to as exophytic. 

Genetic changes in one of several genes are involved in the formation of GISTs. About 80% of cases are associated with a mutation in the KIT gene, and about 10% of cases are associated with a mutation in the PDGFRA gene.

Gastrointestinal Stromal Tumor Market Key Facts

  • As per DelveInsight, the total incident cases of Gastrointestinal Stromal Tumor (GIST) in the US were observed to be 5,090+ in 2017.

  • The stages of Gastrointestinal Stromal Tumor (GIST) are classified into three categories, i.e., localized, regional, distant, and unknown. As per DelveInsight’s estimates, the localized cases account for approximately 60% of the total cases.

  • According to Ma et al. (2015), Gastrointestinal Stromal Tumor (GIST) is more common in males than females with a rate ratio of 1.35.

Gastrointestinal Stromal Tumor (GIST) Market

The Gastrointestinal Stromal Tumor market size is expected to increase during the forecast period owing to the increasing prevalent population along with rise in awareness and disease understanding.

The market outlook section of the report helps to build a detailed comprehension of the historical, current, and forecasted Gastrointestinal Stromal Tumor market size by analyzing the impact of current and emerging therapies in the market. It also provides a thorough assessment of the market drivers & barriers, unmet needs, and emerging technologies.

The report gives complete detail of the Gastrointestinal Stromal Tumor market trend for each marketed drug and late-stage pipeline therapies by evaluating their impact based on the annual cost of therapy, mechanism of action (MoA), competition with other therapies, brand value, and their impact on the market.

Gastrointestinal Stromal Tumor (GIST) Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2019 to 2032. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of diagnosed patient pool and future trends.

Gastrointestinal Stromal Tumor (GIST) Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Gastrointestinal Stromal Tumor market or expected to get launched during the study period. The analysis covers Gastrointestinal Stromal Tumor market uptake by drugs, patient uptake by therapies, and sales of each drug. 

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Gastrointestinal Stromal Tumor Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyses recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Request for Sample PDF Report –

Gastrointestinal Stromal Tumor (GIST) Therapeutics Analysis

Some of the key players in the Gastrointestinal Stromal Tumor (GIST) market include:

  • Advenchen Laboratories

  • Deciphera Pharmaceuticals

  • Pfizer

  • Bayer

  • Blueprint Medicines Corporation

  • Novartis

  • Arog Pharmaceuticals

  • Taiho Oncology

And others.

Gastrointestinal Stromal Tumor (GIST) Therapies covered in the report include:

  • AL3818

  • Ripretinib

  • TAS-116

  • Crenolanib

  • Avapritinib

  • Gleevec

  • Vitrakvi

  • Stivarga

And many others.

Get More Detailed Insights Into the Emerging Therapies & Key Companies –

Table of Content (TOC)

1. Key Insights

2. Executive Summary 

3. Gastrointestinal Stromal Tumor Competitive Intelligence Analysis

4. Gastrointestinal Stromal Tumor Market Overview at a Glance

5. Gastrointestinal Stromal Tumor Disease Background and Overview

6. Gastrointestinal Stromal Tumor Patient Journey

7. Gastrointestinal Stromal Tumor Epidemiology and Patient Population

8. Gastrointestinal Stromal Tumor Treatment Algorithm, Current Treatment, and Medical Practices

9. Gastrointestinal Stromal Tumor Unmet Needs

10. Key Endpoints of Gastrointestinal Stromal Tumor Treatment

11. Gastrointestinal Stromal Tumor Marketed Products

12. Gastrointestinal Stromal Tumor Emerging Therapies

13. Gastrointestinal Stromal Tumor Seven Major Market Analysis

14. Attribute Analysis

15. Gastrointestinal Stromal Tumor Market Outlook (7 major markets)

16. Gastrointestinal Stromal Tumor Access and Reimbursement Overview

17. KOL Views on the Gastrointestinal Stromal Tumor Market.

18. Gastrointestinal Stromal Tumor Market Drivers

19. Gastrointestinal Stromal Tumor Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The Table of Contents (TOC) is not exhaustive; the final content may vary. Refer to the sample report for the complete table of contents.

Download Sample PDF Report –

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.


Other Trending Healthcare Reports by DelveInsight

Varicose Veins Market
Varicose Veins Market” report delivers an in-depth understanding of the Varicose Veins, historical and forecasted epidemiology as well as the Varicose Veins market trends in 7MM.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States